Full name
XENICO PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.89.A - Production of dietary supplements
21.10.Z - Manufacture of basic pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.49.Z - Wholesale trade of other household articles
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
70.20.Z - Business and management consultancy activities
73 - Advertising, market research and public relations
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,6 | 0,2 | 0,7 | 283,2 |
EBITDA | 1,6 | 0,2 | 0,8 | 243 |
Short time liabilities | 2,6 | 2,3 | 3,3 | 48,1 |
Equity capital | 4,3 | 4,4 | 4,9 | 11,7 |
Operating profit (EBIT) | 1,6 | 0,2 | 0,7 | 285 |
Assets | 7,1 | 6,7 | 8,3 | 22,8 |
Net profit (loss) | 1,3 | 0,1 | 0,5 | 346,7 |
Cash | 0,8 | 0,4 | 0,8 | 91,4 |
Net income from sale | 17,3 | 18,1 | 18,5 | 2,1 |
Liabilities and provisions for liabilities | 2,8 | 2,3 | 3,3 | 43,6 |
Working assets | 5,8 | 5,5 | 7 | 27,8 |
Depreciation | 0 | 0 | 0 | 27,5 |
% | % | % | p.p. | |
Profitability of capital | 30,2 | 2,6 | 10,5 | 7,9 |
Equity capital to total assets | 60,2 | 65,3 | 59,4 | -5,9 |
Gross profit margin | 9,1 | 1 | 3,9 | 2,9 |
EBITDA Margin | 9,3 | 1,2 | 4,2 | 3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 55 | 46 | 66 | 20 |
Current financial liquidity indicator | 2.2244319915771484 | 2.4233288764953613 | 2.092088222503662 | -0,3 |
Net dept to EBITDA | -0.24581019580364227 | -0.9813275933265686 | -0.9654778242111206 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane